PL126619B1 - Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form - Google Patents

Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form

Info

Publication number
PL126619B1
PL126619B1 PL1978209080A PL20908078A PL126619B1 PL 126619 B1 PL126619 B1 PL 126619B1 PL 1978209080 A PL1978209080 A PL 1978209080A PL 20908078 A PL20908078 A PL 20908078A PL 126619 B1 PL126619 B1 PL 126619B1
Authority
PL
Poland
Prior art keywords
acid
ethanol
sodium salt
solvate
water
Prior art date
Application number
PL1978209080A
Other languages
English (en)
Polish (pl)
Other versions
PL209080A1 (pl
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL126619(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PL209080A1 publication Critical patent/PL209080A1/xx
Publication of PL126619B1 publication Critical patent/PL126619B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1978209080A 1977-08-17 1978-08-16 Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form PL126619B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
PL209080A1 PL209080A1 (pl) 1979-06-04
PL126619B1 true PL126619B1 (en) 1983-08-31

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978209080A PL126619B1 (en) 1977-08-17 1978-08-16 Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form

Country Status (34)

Country Link
US (1) US4224371A (en, 2012)
EP (1) EP0001024B1 (en, 2012)
JP (1) JPS5441890A (en, 2012)
AT (2) AT366049B (en, 2012)
AU (1) AU520898B2 (en, 2012)
BG (2) BG33888A3 (en, 2012)
CA (1) CA1121343A (en, 2012)
CS (2) CS207646B2 (en, 2012)
DD (1) DD137588A5 (en, 2012)
DE (1) DE2860358D1 (en, 2012)
DK (2) DK152213C (en, 2012)
EG (1) EG13520A (en, 2012)
ES (1) ES472381A1 (en, 2012)
FI (1) FI65433C (en, 2012)
FR (1) FR2400519A1 (en, 2012)
GE (2) GEP19960475B (en, 2012)
GR (1) GR73661B (en, 2012)
HR (1) HRP931395B1 (en, 2012)
HU (1) HU181497B (en, 2012)
IE (1) IE47230B1 (en, 2012)
IL (1) IL55186A (en, 2012)
IT (1) IT1107961B (en, 2012)
MD (2) MD247C2 (en, 2012)
MX (2) MX155976A (en, 2012)
NO (1) NO156168C (en, 2012)
NZ (1) NZ188163A (en, 2012)
OA (1) OA06016A (en, 2012)
PL (1) PL126619B1 (en, 2012)
PT (1) PT68431A (en, 2012)
RO (1) RO79999A (en, 2012)
SI (1) SI7811917A8 (en, 2012)
SU (2) SU799666A3 (en, 2012)
YU (1) YU42166B (en, 2012)
ZA (1) ZA784187B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3283B (lt) 1991-05-17 1995-06-26 Polska Akademia Nauk Instytut Aminotiazolllinių cefalosporino darinių bei jų natrio ir kalio druskų gavimo būdas

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
EP0233255B1 (en) * 1985-08-12 1996-05-29 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3283B (lt) 1991-05-17 1995-06-26 Polska Akademia Nauk Instytut Aminotiazolllinių cefalosporino darinių bei jų natrio ir kalio druskų gavimo būdas

Also Published As

Publication number Publication date
NZ188163A (en) 1981-10-19
US4224371A (en) 1980-09-23
NO156168B (no) 1987-04-27
JPS6145626B2 (en, 2012) 1986-10-08
DK163514C (da) 1992-07-27
DK152213C (da) 1988-07-11
YU42166B (en) 1988-06-30
IL55186A (en) 1981-07-31
CA1121343A (fr) 1982-04-06
PT68431A (fr) 1978-09-01
EG13520A (en) 1982-03-31
MD247B1 (ro) 1995-07-31
MD225C2 (ro) 1995-12-31
CS207646B2 (en) 1981-08-31
JPS5441890A (en) 1979-04-03
CS207647B2 (en) 1981-08-31
IT1107961B (it) 1985-12-02
FR2400519A1 (fr) 1979-03-16
FI65433B (fi) 1984-01-31
RO79999A (ro) 1982-10-11
GEP19960475B (en) 1996-07-22
DK159786A (da) 1986-04-09
HRP931395B1 (en) 1996-04-30
BG33887A3 (bg) 1983-05-16
OA06016A (fr) 1981-06-30
IE47230B1 (en) 1984-01-25
AT366050B (de) 1982-03-10
AT366049B (de) 1982-03-10
DD137588A5 (de) 1979-09-12
FI782494A7 (fi) 1979-02-18
MX155976A (es) 1988-06-06
ATA563578A (de) 1981-07-15
IL55186A0 (en) 1978-09-29
MD225B1 (ro) 1995-06-30
SU852175A3 (ru) 1981-07-30
HU181497B (en) 1983-07-28
IE781669L (en) 1979-02-17
DE2860358D1 (en) 1981-03-12
NO782782L (no) 1979-02-20
YU191778A (en) 1983-02-28
SU799666A3 (ru) 1981-01-23
GEP19960476B (en) 1996-07-22
NO156168C (no) 1987-08-19
PL209080A1 (pl) 1979-06-04
DK152213B (da) 1988-02-08
IT7850648A0 (it) 1978-08-08
FI65433C (fi) 1984-05-10
AU3896578A (en) 1980-02-21
ES472381A1 (es) 1979-03-16
DK159786D0 (da) 1986-04-09
ATA52280A (de) 1981-07-15
AU520898B2 (en) 1982-03-04
SI7811917A8 (en) 1997-12-31
EP0001024B1 (fr) 1981-01-21
BG33888A3 (bg) 1983-05-16
MX5448E (es) 1983-08-09
FR2400519B1 (en, 2012) 1980-05-16
DK361078A (da) 1979-02-18
GR73661B (en, 2012) 1984-03-28
MD247C2 (ro) 1995-12-31
ZA784187B (en) 1979-09-26
EP0001024A1 (fr) 1979-03-07
DK163514B (da) 1992-03-09

Similar Documents

Publication Publication Date Title
PL126619B1 (en) Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form
RU2118959C1 (ru) ГИДРОХЛОРИД 7β-[(Z)-2-(2-АМИНО-4-ТИАЗОЛИЛ)-2-ГИДРОКСИИМИНОАЦЕТАМИДО]-3-(1,2,3-ТРИАЗОЛ-4-ИЛ)-ТИОМЕТИЛТИО-3-ЦЕФЕМ-4-КАРБОНОВОЙ КИСЛОТЫ, ЕГО КРИСТАЛЛОГИДРАТ И СПОСОБ ИХ ПОЛУЧЕНИЯ
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
RU1787158C (ru) Способ получени цефемовых соединений или их аддитивных солей с кислотами
JP6160621B2 (ja) ピロロキノリンキノンテトラアルカリ塩及びその結晶、これらの製造方法、並びに、組成物
JPS62174018A (ja) 細菌性感染症治療剤
JPH045038B2 (en, 2012)
EP0157538A2 (en) Improvements in or relating to crystalline ceftazidime salts
AU2006300882B2 (en) Crystalline sodium salt of cephalosporin antibiotic
SE444683B (sv) Syn-isomerer av 3-substituerade 7-amino-tiazolyl-acetamido-cefalosporansyraforeningar och farmaceutiska kompositioner till anvendning mot gram-positiva och gram-negativa bakterier
US4943632A (en) Ceftazidime dihydrochloride formic acid solvates
JPH0324086A (ja) 結晶質セフェム酸付加塩およびそれらの製法
DD261163A5 (de) Verfahren zur reinigung von cephalosporin-antibiotika
HU181961B (en) Process for producing new oxime derivatives of 3-thiadiazolythio-methyl-7-aminothiazolylacetamido-ceph-3-eme-4-carboxylic acids
KR880001299B1 (ko) 7β-(2D-2-아미노-2-카르복시-에틸티오아세트아미드)-7α-메톡시-3-(1-메틸-1H-테트라졸-5-일)-티오메틸-3-세펨-4-카르본산나트륨염 7수화물의 제조방법
US3859362A (en) Alkyl-2,3,3-triiodoallyl ethers and process for their preparation and a composition containing the same
AT337900B (de) Verfahren zur herstellung von neuen cephemderivaten sowie ihren estern und salzen
CS195747B2 (cs) Způsob výroby krystalické bezvodé sodné soli cefamandolu
GB1574180A (en) N-(4-cyano-1-methyl-3-(1-methyl-5-nitroimidazol-2-yl)pyrazol-5-yl)-oxamic acid derivatives
HU202537B (en) Process for producing cefemcarboxylic acid derivatives
DD137588C4 (de) Verfahren zur Herstellung einer Kristailform von 7-Amino-thiazolyl-azetamidozephalosporansäuresalzen
GB2024826A (en) Salts of (-) cis-1,2- epoxypropylphosphonic acid
PL163938B1 (pl) Sposób wytwarzania uwodnionej soli sodowej kwasu 7-[2-/2-aminotiazol-4-ilo/-2-/Z/- metoksyiminoacetamido] -cefalosporanowego w postaci krystalicznej
DE1931722A1 (de) Alpha-Amino-cyclohexadienyl-alkylen-penicilline und -cephalosporine,ihre Salze,und Verfahren zu ihrer Herstellung
JPS6038383A (ja) ５‐シクロプロピル‐５，８‐ジヒドロ‐８‐オキソ‐１，３‐ジオキソロ〔４，５‐ｇ〕キノリン‐７‐カルボン酸、その製法及びそれを含有する抗バクテリア剤